Also trades as: HSCS (NASDAQ) · $vol 10M
HSCSW NASDAQ
HeartSciences Inc.
1W: +0.2%
1M: +11.9%
3M: -35.0%
YTD: -8.6%
1Y: -66.5%
$0.05
+0.00 (+5.03%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0437-0.08
Volume4
Avg Volume1,690
Beta1.86
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAndrew Simpson
Employees14
SectorHealthcare
IndustryMedical - Devices
IPO Date2022-06-15
Websiteheartsciences.com
550 Reserve Street
Southlake, TX 76092
US
Southlake, TX 76092
US
682-237-7781
About HeartSciences Inc.
Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals. Founded in 2007, the firm's operations are headquartered in Southlake, Texas.
Latest News
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wells David R. | A-Award | 15,000 | — | 2026-01-12 |
| Bent Bruce | A-Award | 15,000 | — | 2026-01-12 |
| HILZ MARK T | A-Award | 45,000 | — | 2025-12-22 |
| Szymczak Brian | A-Award | 15,000 | — | 2025-12-22 |
| Watson Danielle | A-Award | 15,000 | — | 2025-12-22 |